A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1

Published:2019-08 Issue:4 Volume:29 Page:420-427
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Block Matthew S.,Nevala Wendy K.,Pang Yuan-Ping,Allred Jacob B.,Strand Carrie,Markovic Svetomir N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference28 articles.

1. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.;Edge;Ann Surg Oncol,2010

2. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.;Markovic;Mayo Clin Proc,2007

3. Interferon alpha for the adjuvant treatment of cutaneous melanoma.;Mocellin;Cochrane Database Syst Rev,2013

4. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy.;Eggermont;N Engl J Med,2016

5. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma.;Weber;N Engl J Med,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating silver nanoparticles and resiquimod as a local melanoma treatment;European Journal of Pharmaceutics and Biopharmaceutics;2023-02

2. Adipocytes Encapsulating Telratolimod Recruit and Polarize Tumor‐Associated Macrophages for Cancer Immunotherapy;Advanced Science;2022-12-16

3. MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses;Frontiers in Immunology;2022-08-19

4. Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma;Journal for ImmunoTherapy of Cancer;2021-08

5. Large, Anionic Liposomes Enable Targeted Intraperitoneal Delivery of a TLR 7/8 Agonist To Repolarize Ovarian Tumors’ Microenvironment;Bioconjugate Chemistry;2021-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3